Pablo J. Cagnoni

Companies

• IncytePresident Jun 7, 2023 to now¹
• Fusion PharmaceuticalsBoard member Jun 25, 2020 to Jun 4, 2024²
• Rubius Therapeutics (United States)Board member Jul 17, 2018 to Feb 1, 2023³
• Rubius Therapeutics (United States)President Apr 15, 2020 to Feb 14, 2022⁴
• Rubius Therapeutics (United States)Chief executive officer Jul 17, 2018 to Feb 14, 2022³
• TURMERIC ACQUISITION CORP.Board member Oct 15, 2020 to Oct 15, 2020⁵
• CRISPR TherapeuticsBoard member Oct 18, 2016 to Nov 21, 2019⁶
• Onyx PharmaceuticalsEVP, Global R&D and Tech Ops Mar 13, 2013 to Oct 3, 2013⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Incyte INCY183,200 shares⁸$20.8M at $113.77Sep 15, 2026
• Rubius Therapeutics (United States)66,082 shares⁹Feb 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 13,985 shares at $120.49 of Incyte⁸
• Sep 15, 2026Sold 9,233 shares at $120.50 of Incyte⁸
• Sep 15, 2026Exercised options 9,233 shares at $71.93 of Incyte⁸
• Sep 15, 2026Exercised options 6,477 shares at $64.25 of Incyte⁸
• Sep 15, 2026Exercised options 4,551 shares at $61.18 of Incyte⁸
• Sep 15, 2026Exercised options 2,957 shares at $61.76 of Incyte⁸
• Aug 19, 2026Sold 10,801 shares at $125.56 of Incyte¹⁰
• Aug 12, 2026Sold 10,803 shares at $120.04 of Incyte¹¹
• Aug 5, 2026Sold 10,640 shares at $122.69 of Incyte¹²
• Jul 31, 2026Sold 15,888 shares at $119.70 of Incyte¹³
• Jul 16, 2026Granted 13,403 shares of Incyte¹⁴
• Jul 15, 2026Shares withheld for tax 4,950 shares at $115.09 of Incyte¹⁵
• Jul 14, 2026Shares withheld for tax 17,969 shares at $114.88 of Incyte¹⁵
• Jun 1, 2026Shares withheld for tax 25,469 shares at $95.59 of Incyte¹⁶
• May 6, 2026Granted 31,517 shares of Incyte¹⁷
• Apr 17, 2026Sold 18,667 shares at $96.50 of Incyte¹⁸
• Apr 17, 2026Exercised options 12,590 shares at $71.93 of Incyte¹⁸
• Apr 17, 2026Exercised options 6,077 shares at $64.25 of Incyte¹⁸
• Apr 15, 2026Granted 27,892 shares of Incyte¹⁹
• Mar 17, 2026Sold 18,667 shares at $94.24 of Incyte²⁰
• Mar 17, 2026Exercised options 11,501 shares at $64.25 of Incyte²⁰
• Mar 17, 2026Exercised options 7,166 shares at $61.18 of Incyte²⁰
• Feb 19, 2026Sold 18,668 shares at $100.91 of Incyte²¹
• Feb 19, 2026Exercised options 5,575 shares at $61.18 of Incyte²¹
• Feb 19, 2026Exercised options 13,093 shares at $61.76 of Incyte²¹